Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal sufentanil with ropivacaine versus bupivacaine for elective cesarean section
IRCT20130926014779N7Phase 2Completed
- Sponsor
- Jahrom University of Medical Sciences
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in pain and postanesthetic shivering (PAS) comparing Sufentanil + bupivacaine with Sufentanil + ropivacaine (2 arms). Primary endpoints: Pain and Chills. Started Dec 2019; status: completed.
02
Drugs
sufentanilropivacainebupivacaine
03
Conditions
painpostanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20130926014779N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130926014779N7.